NNC 0129-0000-1003
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for NNC 0129-0000-1003, covering 2017-02-10 to 2020-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A [Phase 3]